Literature DB >> 29601946

Calculated cell-specific intracellular hydrogen peroxide concentration: Relevance in cancer cell susceptibility during ascorbate therapy.

Dieanira Erudaitius1, Jacqueline Mantooth1, Andrew Huang2, Jesse Soliman1, Claire M Doskey3, Garry R Buettner4, Victor G J Rodgers5.   

Abstract

The high extracellular hydrogen peroxide (H2O2) concentrations generated during pharmacological ascorbate (P-AscH-) therapy has been shown to exhibit a high flux into susceptible cancer cells leading to a decrease in clonogenic survival. It is hypothesized that the intracellular H2O2 concentration for susceptibility is independent of cell type and that the variation observed in dosing is associated with differences in the cell-specific overall steady-state intracellular H2O2 concentration values. The steady-state variation in intracellular H2O2 concentration is coupled to a number of cellular specific transport and reaction factors including catalase activity and membrane permeability. Here a lumped-parameter mathematical modeling approach, assuming a catalase-dominant peroxide removal mechanism, is used to calculate intracellular H2O2 concentration for several cell lines. Experimental measurements of critical parameters pertaining to the model are obtained. The cell lines investigated are normal pancreatic cells, H6c7, the pancreatic cancer cell line, MIA PaCa-2 and the glioblastoma cell lines, LN-229, T98G, and U-87; all which vary in susceptibility. The intracellular H2O2 concentration estimates are correlated with the clonogenic surviving fraction for each cell line, in-vitro. The results showed that, despite the fact that the experimental parameters including catalase concentration and plasma membrane permeability demonstrated significant variability across cell lines, the calculated steady-state intracellular to extracellular H2O2 concentration ratio did not vary significantly across cell lines. Thus, the calculated intracellular H2O2 concentration is not unique in characterizing susceptibility. These results imply that, although intracellular H2O2 concentration plays a key role in cellular susceptibility to P-AscH- adjuvant therapy, its overall contribution in a unifying mechanism across cell types is complex.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Catalase; Cytosol; Hydrogen peroxide; Intracellular hydrogen peroxide concentration; Mathematical model; Parameter sensitivity; Peroxisome permeability; Pharmacological ascorbate therapy; Plasma membrane permeability; Transport properties of cells

Mesh:

Substances:

Year:  2018        PMID: 29601946      PMCID: PMC6160292          DOI: 10.1016/j.freeradbiomed.2018.03.044

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  47 in total

1.  Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.

Authors:  John A Cieslak; Robert K Strother; Malvika Rawal; Juan Du; Claire M Doskey; Samuel R Schroeder; Anna Button; Brett A Wagner; Garry R Buettner; Joseph J Cullen
Journal:  Free Radic Biol Med       Date:  2015-02-26       Impact factor: 7.376

2.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

3.  Clonogenic assay of cells in vitro.

Authors:  Nicolaas A P Franken; Hans M Rodermond; Jan Stap; Jaap Haveman; Chris van Bree
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2).

Authors:  P Lipiński; J C Drapier; L Oliveira; H Retmańska; B Sochanowicz; M Kruszewski
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

5.  High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.

Authors:  Yan Ma; Julia Chapman; Mark Levine; Kishore Polireddy; Jeanne Drisko; Qi Chen
Journal:  Sci Transl Med       Date:  2014-02-05       Impact factor: 17.956

6.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

7.  Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.

Authors:  J L Welsh; B A Wagner; T J van't Erve; P S Zehr; D J Berg; T R Halfdanarson; N S Yee; K L Bodeker; J Du; L J Roberts; J Drisko; M Levine; G R Buettner; J J Cullen
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-05       Impact factor: 3.333

8.  A metabolic model describing the H2O2 elimination by mammalian cells including H2O2 permeation through cytoplasmic and peroxisomal membranes: comparison with experimental data.

Authors:  Nobuo Makino; Kayoko Sasaki; Kanae Hashida; Yuki Sakakura
Journal:  Biochim Biophys Acta       Date:  2004-08-04

9.  Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation.

Authors:  Malvika Rawal; Samuel R Schroeder; Brett A Wagner; Cameron M Cushing; Jessemae L Welsh; Anna M Button; Juan Du; Zita A Sibenaller; Garry R Buettner; Joseph J Cullen
Journal:  Cancer Res       Date:  2013-06-13       Impact factor: 12.701

10.  Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress.

Authors:  Christoph Klingelhoeffer; Ulrike Kämmerer; Monika Koospal; Bettina Mühling; Manuela Schneider; Michaela Kapp; Alexander Kübler; Christoph-Thomas Germer; Christoph Otto
Journal:  BMC Complement Altern Med       Date:  2012-05-02       Impact factor: 3.659

View more
  6 in total

1.  The latency of peroxisomal catalase in terms of effectiveness factor for pancreatic and glioblastoma cancer cell lines in the presence of high concentrations of H2O2: Implications for the use of pharmacological ascorbate in cancer therapy.

Authors:  Dieanira T Erudaitius; Garry R Buettner; Victor G J Rodgers
Journal:  Free Radic Biol Med       Date:  2020-06-06       Impact factor: 7.376

2.  Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage.

Authors:  Visarut Buranasudja; Claire M Doskey; Adrienne R Gibson; Brett A Wagner; Juan Du; David J Gordon; Stacia L Koppenhafer; Joseph J Cullen; Garry R Buettner
Journal:  Mol Cancer Res       Date:  2019-07-23       Impact factor: 5.852

Review 3.  Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.

Authors:  Jaime González-Montero; Silvia Chichiarelli; Margherita Eufemi; Fabio Altieri; Luciano Saso; Ramón Rodrigo
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

4.  The Quest to Quantify Selective and Synergistic Effects of Plasma for Cancer Treatment: Insights from Mathematical Modeling.

Authors:  Charlotta Bengtson; Annemie Bogaerts
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

Review 5.  Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer.

Authors:  Miguel Sánchez-Álvarez; Raffaele Strippoli; Massimo Donadelli; Alexandr V Bazhin; Marco Cordani
Journal:  Cancers (Basel)       Date:  2019-09-22       Impact factor: 6.639

6.  Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells in vitro.

Authors:  Eric Freund; Kim-Rouven Liedtke; Lea Miebach; Kristian Wende; Amanda Heidecke; Nagendra Kumar Kaushik; Eun Ha Choi; Lars-Ivo Partecke; Sander Bekeschus
Journal:  Cancers (Basel)       Date:  2020-01-02       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.